BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18085720)

  • 1. The role of peptides in blood-brain barrier nanotechnology.
    Teixidó M; Giralt E
    J Pept Sci; 2008 Feb; 14(2):163-73. PubMed ID: 18085720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA
    Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chapter 4 - Applications of nanotechnology in molecular imaging of the brain.
    McAteer MA; Choudhury RP
    Prog Brain Res; 2009; 180():72-96. PubMed ID: 20302829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug delivery to the brain with nanoparticles].
    Aliautdin RN; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 2003; 66(2):65-8. PubMed ID: 12962052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of nanotechnology to imaging and therapy of brain tumors.
    Mohs AM; Provenzale JM
    Neuroimaging Clin N Am; 2010 Aug; 20(3):283-92. PubMed ID: 20708547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain drug targeting: a computational approach for overcoming blood-brain barrier.
    Mehdipour AR; Hamidi M
    Drug Discov Today; 2009 Nov; 14(21-22):1030-6. PubMed ID: 19647097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides: important tools for the treatment of central nervous system disorders.
    Malavolta L; Cabral FR
    Neuropeptides; 2011 Oct; 45(5):309-16. PubMed ID: 21477861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug and gene targeting to the brain with molecular Trojan horses.
    Pardridge WM
    Nat Rev Drug Discov; 2002 Feb; 1(2):131-9. PubMed ID: 12120094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid peptide drug development: transport of opioid chimeric peptides through the blood-brain barrier.
    Pardridge WM
    NIDA Res Monogr; 1992; 120():153-68. PubMed ID: 1501684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophins, neuroprotection and the blood-brain barrier.
    Pardridge WM
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1753-7. PubMed ID: 12528312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
    Pardridge WM
    Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Discov Med; 2006 Aug; 6(34):139-43. PubMed ID: 17234133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.